Stocks
Nasus Pharma Ltd.NSRX
AMEXHealthcareBiotechnology$3.49
Price as of · delayed, not real-time
A specialty pharmaceutical company focused on developing intranasal emergency treatments, including a naloxone product for opioid overdose. Its lead candidate targets a niche in rapid-response drug delivery, and investors track it for its potential in the growing opioid reversal market.
52W Range: $1.98-$9.50
Congressional Interest in Nasus Pharma Ltd. (NSRX)
No congressional trades have been disclosed for Nasus Pharma Ltd. (NSRX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading NSRX?
No congressional trades found for this stock.